drugset / Trial / NCT00592488

Acetyl-L-Carnitine in the Treatment of Septic Shock

NCT00592488

Phase 1/2 Completed 13 enrolled Vanderbilt University
RandomizedCrossoverQuadruple-blindTreatment

Summary

This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic shock requiring vasopressors.

Timeline

Start
2006-08
Primary completion
2009-08
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcarnitine Small molecule 8 g Intravenous